23andMe (ME)
(Real Time Quote from BATS)
$0.32 USD
0.00 (-0.87%)
Updated Aug 28, 2024 11:02 AM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for 23andMe Holding Co falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | 220 | 299 | 272 | 0 | 305 |
Cost Of Goods | 120 | 165 | 139 | 0 | 168 |
Gross Profit | 99 | 135 | 133 | 0 | 137 |
Selling & Adminstrative & Depr. & Amort Expenses | 781 | 459 | 387 | 3 | 181 |
Income After Depreciation & Amortization | -681 | -324 | -254 | -3 | -44 |
Non-Operating Income | 15 | 10 | 33 | 26 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -667 | -314 | -221 | 23 | 0 |
Income Taxes | 0 | -3 | -3 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -667 | -312 | -217 | 23 | 0 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -667 | -312 | -217 | 23 | 0 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -300 | -288 | -228 | -3 | -21 |
Depreciation & Amortization (Cash Flow) | 381 | 37 | 26 | 0 | 23 |
Income After Depreciation & Amortization | -681 | -324 | -254 | -3 | -44 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | 475.98 | 451.50 | 361.53 | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.67 | -0.69 | -0.57 | NA | NA |
Diluted Net EPS (GAAP) | -1.40 | -0.69 | -0.60 | NA | -0.01 |
Fiscal Year end for 23andMe Holding Co falls in the month of March .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 40.41 | 64.03 | 44.75 | 50.00 | 60.86 |
Cost Of Goods | 19.90 | 37.00 | 24.81 | 28.27 | 30.18 |
Gross Profit | 20.51 | 27.03 | 19.94 | 21.73 | 30.68 |
SG&A, R&D, and Dept/Amort Expenses | 92.47 | 238.89 | 301.15 | 100.86 | 139.95 |
Income After SG&A, R&D, and Dept/Amort Expenses | -71.96 | -211.86 | -281.21 | -79.13 | -109.27 |
Non-Operating Income | 2.56 | 3.05 | 3.25 | 3.90 | 4.64 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -69.40 | -208.82 | -277.96 | -75.23 | -104.62 |
Income Taxes | 0.00 | 0.02 | 0.02 | 0.04 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -69.40 | -208.83 | -277.98 | -75.27 | -104.62 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -69.40 | -208.83 | -277.98 | -75.27 | -104.62 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 495.89 | 485.95 | 480.81 | 474.86 | 462.25 |
Diluted EPS Before Non-Recurring Items | -0.14 | -0.12 | -0.17 | -0.16 | -0.22 |
Diluted Net EPS (GAAP) | -0.14 | -0.43 | -0.58 | -0.16 | -0.23 |